帕金森病非运动症状及药物治疗研究进展

神经药理学报 ›› 2013, Vol. 3 ›› Issue (6): 44-47.

帕金森病非运动症状及药物治疗研究进展

王金

河北北方学院药学系，张家口，075000，中国

出版日期:2013-12-26 发布日期:2014-06-27
作者简介:王金，男，讲师，硕士；研究方向：中药新药研究开发；Tel：+86-0313-4029305；E-mail：wangjinzym@163.com
基金资助:
河北省卫生厅资助项目（No.20110173），河北省教育厅资助项目（No.Z2011304）

Non-motor Symptoms of Parkinson’s Disease

WANG Jin

Department of Pharmacy, Hebei North University, Zhangjiakou, 075000, China

Online:2013-12-26 Published:2014-06-27
About author:王金，男，讲师，硕士；研究方向：中药新药研究开发；Tel：+86-0313-4029305；E-mail：wangjinzym@163.com
Supported by:
河北省卫生厅资助项目（No.20110173），河北省教育厅资助项目（No.Z2011304）

摘要/Abstract

摘要： 帕金森病（Parkinson’s disease，PD）是以运动功能异常和非运动症状为特征的中枢神经退行性疾病。非运动症状包括睡眠障碍、神经精神病学障碍、认知功能障碍、自主神经系统障碍、胃肠道功能紊乱和感觉症状等。由于缺乏足够的认识和重视，这些症状常被忽视或误诊，严重影响到帕金森病患者的生活质量。该文对帕金森病非运动症状的表现及治疗进展做一综述。

关键词: 帕金森病, 非运动症状, 综述

Abstract: Parkinson’s disease (PD) is a progressive，disabling neurodegenerative disorder with onset of motor and non-motor features. Non-motor symptoms include sleep disorders，neuropsychiatric symptoms，cognitive impairment，autonomic dysfunction，gastrointestinal and sensory symptoms. These symptoms are important factors related quality of life affected PD patients. This article will provide an overview of the non-motor symptoms of PD and their treatment options.

Key words: Parkinson&, rsquo, s disease, non-motor symptoms, review

中图分类号:

R964

王金. 帕金森病非运动症状及药物治疗研究进展[J]. 神经药理学报, 2013, 3(6): 44-47.

WANG Jin. Non-motor Symptoms of Parkinson’s Disease[J]. Acta Neuropharmacologica, 2013, 3(6): 44-47.

参考文献

[1] Sara Varanese, Zoe Birnbaum, Roger Rossi, et al. Treatment of advanced Parkinson’s disease[J].Parkinsons Dis, 2011, 2010: 480260.

[2] Cynthia L Commella. Sleep disturbances in Parkinson’s disease[J] .Curr Neurol Neurosci Rep, 2003, 10(3):173–180.

[3] I Eisensehr, R linke, S Noachtar, et al. Reduced striatal dopamine transports in idiopathic rapid eye movement sleep behaviour disorder.comparasion with parkinson’s disease[J]. Brain, 2000, 123(Pt6): 1155-1160.

[4] B F Boeve, M H Silber, J E Parisi, et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism[J]. Neurology, 2003, 61(1): 40–45.

[5] J F Gagnon, M A Bedard, M L Fantini, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease [J]. Neurology, 2002, 59(4):585–589.

[6] R D Abbott, G W Ross, L R White, et al. Excessive daytime sleepiness and the future risk of Parkinson’s disease [J]. Mov Disord, 2005, 20(10):S101.

[7] Thomas Müller. Drug therapy in patients with Parkinson’s disease [J]. Translational Neurodegeneration, 2012, 1:10.

[8] Sze-Ee Soh, Meq E Morris, Jennifer L McGinley. Determinants of health-related quality of life in Parkinson’s disease: a systematic review [J].Parkinsonism Relat Disord, 2011, 17(1):1-9.

[9] J Schwarz, P Odin, C Buhmann, et al. Depression in Parkinson’s disease [J]. J Neurol, 2011, 258(suppl 2):S336-S338.

[10] Laura Marsh. Neuropsychiatric aspects of Parkinson’s disease [J]. Psychosmatics, 2000, 41(1):15-23.

[11] 周晓雯，苏朝芬，罗焕敏. 线粒体与神经退行性疾病[J].神经药理学报，2011，1(3)：41-46.

[12] 薛占霞，彭亮. 情感性精神障碍疾病治疗药物的研究现状[J].神经药理学报，2011，1(3)：55-64.

[13] Ziemssen Tjalf, Heinz Reichmann. Non-motor dysfunction in Parkinson’s disease [J]. Parkinsonism related disorder, 2007, 13(6):323332.

[14] I H Richard, R B Schiffer, R Kurlan. Anxiety and Parkinson’s disease [J]. J Neuropsychiatry Clin Neurosci, 1996, 8:383-392.

[15] Manmohan Mehndiratta, Rohit K Garg, Sanjay Pandey. Nonmotor symptom complex of Parkinson's disease--an under-recognized entity [J]. J Assoc Physicians India, 2011, 59: 302-308.

[16] E C Lauterbach, R C Duvoisin. Anxiety disorders in familial parkinsonism [J]. Am J Psychiatry, 1992, 148(2):274.

[17] Jennifer G Goldman. New thoughts on thought disorders in Parkinson’s disease: review of current research strategies and challenges [J]. Parkinsons Dis, 2011, 2011:675630.

[18] 王新，于谭方，王平. 帕金森病患者非运动症状的研究进展 [J].国际神经病学神经外科杂志，2011（38）2:139-142.

[19] Angie A Kehagia, Roger A Baker, Trevor W Robbins. Neuropsychological and clinical heterogeneity of congnitive impariment and dementia in patients with Parkinson’s disease [J]. Lancet Neurol, 2010, 9(12): 1200-1213.

[20] Murat Emre. Demetia associated with Parkinson’s disease [J]. Lancet Neurol, 2003, 2(4): 229–237.

[21] Lehana Yeo, Rajindra Singh, Mohan Gundeti, et al. Urinary tract dysfunction in Parkinson’s disease: a review [J]. Int Urol Nephrol, 2012, 44(2):415-424.

[22] Michael S Okun, Benjamin L Walter, William M McDonald, et al. Beneficial effects of testosterone replacement for the non motor symptoms of Parkinson’s disease [J]. Arch Neurol, 2002, 59(11):1750-1753.

[23] Francesca Romana Pezzella, Carlo Colosimo, Nicola Vanacore, et al. Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson’s disease [J].Mov Disord, 2005, 20(1):77-81.

[24] R D Abbott, H Petrovitch, L R White, et al. Frequency of bowel movements and future risk of Parkinson’s disease[J]. Neurology, 2001, 57(3):456-462.

[25] Quinn NP, Koller WC, Lang AE, et al. Painful Parkinson’s disease [J].Lancet, 1996, 1:1366-1369.

[26] W Poewe. Nonmotor symptoms in Parkinson’s disease. In: Jankovic J, Tolosa E, eds. Parkinson’s disease and movement disorders [M]. 5th. Philadelphia: Lippincott Williams and Wilkins, 2007:67-76.

[27] Andrew Siderowf, Danna Jdennings, James Connolly, et al. Risk factors for Parkinson’s disease and impaired olfaction in relatives of patients with Parkinson’s disease[J]. Mov Disord, 2007, 22(15):2249-2255.

[28] G Webster Ross, Helen Petrovitch, Robert D Abbott, et al. Association of olfactory dysfunction with risk for future Parkinson’s disease [J]. Ann Neurol, 2008, 63(2):167-173.